Mild intestinal metaplasia in chronic atrophic antral gastritis can be effectively managed through medication, dietary adjustments, and regular check-ups. Long-term inflammatory stimulation of the gastric mucosa may lead to intestinal metaplasia, requiring timely intervention to prevent disease progression.
1. Drug therapy is an important means of controlling the disease. Proton pump inhibitors such as omeprazole and lansoprazole can reduce gastric acid secretion and relieve gastric mucosal damage; gastric mucosal protectants such as sucralfate and rebamipide can promote mucosal repair; antibiotics such as amoxicillin and clarithromycin can eradicate Helicobacter pylori and reduce recurrence of inflammation.
2. Dietary adjustments can help reduce the burden on the stomach. Avoid spicy, greasy, excessively cold or hot foods, and choose easily digestible foods such as porridge, steamed fish, and boiled vegetables; eat smaller, more frequent meals and avoid overeating; quit smoking and drinking to reduce irritation to the gastric mucosa.
3. Regular check-ups are crucial for monitoring the condition. It is recommended to have a gastroscopy and pathological biopsy every 6-12 months to assess changes in the gastric mucosa; adjust the treatment plan according to the doctor's advice, and avoid stopping medication on your own or abusing drugs.
Mild intestinal metaplasia in chronic atrophic antral gastritis requires long-term management. Patients should actively cooperate with treatment, adjust their lifestyle, and have regular follow-ups to slow disease progression, reduce the risk of cancer, and maintain good gastric health.